Point-of-Care Products & Reviews

BioReady Gold Nanospheres - Bare (Citrate) - 40 nm, 20 OD in aqueous 0.02 mM sodium citrate

BioReady Gold Nanospheres - Bare (Citrate) - 80 nm, 20 OD in aqueous 0.02 mM sodium citrate

BioReady Gold Nanospheres - Streptavidin - 40 nm, 10 OD in aqueous conjugation buffer

BioReady Gold Nanoshells - Streptavidin - 150 nm, 10 OD in aqueous conjugation buffer

Designed with input from top molecular diagnostic assay manufacturers, the RapiDxFire Lyo-Flex 1-Step RT-qPCR 5x Master Mix supports the development of diagnostic devices and assays that meet healthcare provider and consumer demand for fast, accurate results. With consistent results in a liquid state at room temp or in a lyophilised state, this master mix will help you achieve predictable performance in unpredictable conditio…

From collecting samples to reading results, the Q-POC™ SARS-CoV-2 assay has been developed considering patient and user experience at every step of the COVID-19 testing process. The test delivers rapid PCR results in approximately 30 minutes at the Point of Need, on the accurate and portable Q-POC™ platform.

Diagnosing, treating and managing clinically similar respiratory infections can be challenging.  The Q-POC™ SARS-CoV-2, Flu A/B & RSV multiplex assay provides rapid detection and differentiation of three leading respiratory diseases in just ~35 minutes. Running on the “one sample, one test” portable Q-POC™ platform, the test provides results you can trust at the Point of Need.

This new generation analyzer Microsemi CRP LC-767G is more compact and proposes enhanced software and network connectivity providing higher memory, usability plus a new ratio: Granulocytes-to-Lymphocytes Ratio (GLR).

Next-generation point of care diagnostic platform - Next-generation microfluidic technology on the LumiraDx Platform enables lab-comparable performance across a broad menu of diagnostic assays.

The LumiraDx CRP Test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify CRP levels in whole blood and plasma. Used with the LumiraDx Platform, the Test delivers rapid, quantitative results in 4 minutes at the point of care.

The LumiraDx D-Dimer Test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify D-Dimer levels in whole blood and plasma. It is the only direct fingerstick D-Dimer assay available today*, aiding healthcare professionals to exclude deep vein thrombosis (DVT) and pulmonary embolism (PE) in symptomatic patients with confidence** - in only 6 minutes.

The LumiraDx HbA1c test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify HbA1c in fingerstick and venous whole blood. Used with the LumiraDx Platform, the LumiraDx HbA1c test delivers rapid, reliable results in approximately < 7 minutes at the point of care.

The LumiraDx INR Test measures prothrombin time reported as International Normalized Ratio (INR) from a single, direct fingerstick blood sample – all in less than 90 seconds*. The Test is used for monitoring patients on oral anticoagulation therapy with Vitamin-K Antagonist (VKA) drugs. Used with the LumiraDx Instrument, the Test delivers rapid results at the point of care.

The LumiraDx NT-proBNP test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify NT-proBNP in human capillary and venous whole blood and plasma samples (Lithium Heparin). Used with the LumiraDx Platform, the LumiraDx NT-proBNP test delivers rapid, reliable results in 12 minutes at the point of care.

The LumiraDx SARS-CoV-2 Ab Test is a microfluidic immunofluorescence assay for qualitative detection of total antibodies to SARS-CoV-2 in human whole blood (capillary fingerstick or venous), plasma or serum for indication of recent or prior infection. Used with the LumiraDx Platform the Test delivers rapid results at the point of care.

The LumiraDx SARS-CoV-2 Ag Test is a microfluidic immunofluorescence assay for the direct and qualitative detection of nucleocapsid protein antigen in nasal and nasopharyngeal swab specimens from individuals suspected of COVID-19 or asymptomatic individuals. Used with the LumiraDx Platform the test delivers rapid results at the point of care.

Lab-comparable results in just 5 minutes - With excellent performance and results in just 5 minutes, the LumiraDx SARS-CoV-2 Ag Ultra test enables you to accurately and confidently test more patients, optimize clinic workflows and help triage patients without delay

The LumiraDx SARS-CoV-2 Ag Pool Test is a rapid microfluidic immunofluorescence assay for the qualitative detection of the nucleocapsid protein antigen in nasal or nasopharyngeal swab specimens pooled from up to 5 individuals suspected of COVID-19 or up to 5 asymptomatic individuals. Used with the LumiraDx Platform the test offers a rapid, scalable and cost-effective screening solution for infectious individuals.

Is it COVID-19? Is it Flu? Lab-comparable results in minutes. Verify potential infection quickly with a rapid microfluidic assay that provides actionable and lab-comparable results in 12 mins for patients suspected of Flu and/or COVID-19, to help decision making and guide treatment.

EVIK™ DxSpheres - A solid assay solution. EVIK DxSpheres are precise-durable spheres, originating from a few uL drops of liquid reagent mix. EVIK helps assay developers solve the common challenge of reagent stability by incorporating reagent(s) into stable lyophilized beads that are versatile for use in micro-fluidic cartridges or other custom devices.

For an IVD medical device that enhances any clinical diagnostics lab, turn to the MassTrak ACQUITY UPLC I-Class PLUS/Xevo TQ-S micro IVD System.

Perform routine multi-analyte analysis in your clinical diagnostics lab with the MassTrak ACQUITY UPLC I-Class PLUS/Xevo TQD IVD System.

The SPOTFIRE System is the latest advancement in molecular infectious disease diagnostics for use at the point-of-care.

Run on the BIOFIRE ® SPOTFIRE ® System, the SPOTFIRE R Panel tests for 15 of the most likely respiratory targets, including viruses and bacteria, with results in about 15 minutes. 

Run on the BIOFIRE ® SPOTFIRE ® System, the SPOTFIRE R Panel Mini tests for 5 of the most probable viruses that cause respiratory tract infections in about 15 minutes.